<SEC-DOCUMENT>0001144204-15-016449.txt : 20150316
<SEC-HEADER>0001144204-15-016449.hdr.sgml : 20150316
<ACCEPTANCE-DATETIME>20150316171658
ACCESSION NUMBER:		0001144204-15-016449
CONFORMED SUBMISSION TYPE:	SC 13D
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20150316
DATE AS OF CHANGE:		20150316
GROUP MEMBERS:		DAN OREN

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TEKMIRA PHARMACEUTICALS Corp
		CENTRAL INDEX KEY:			0001447028
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				980597776
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-85963
		FILM NUMBER:		15704006

	BUSINESS ADDRESS:	
		STREET 1:		100-8900 GLENLYON PARKWAY
		CITY:			BURNABY
		STATE:			A1
		ZIP:			V5J 5J8
		BUSINESS PHONE:		604-419-3200

	MAIL ADDRESS:	
		STREET 1:		100-8900 GLENLYON PARKWAY
		CITY:			BURNABY
		STATE:			A1
		ZIP:			V5J 5J8

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TEKMIRA PHARMACEUTICALS CORP
		DATE OF NAME CHANGE:	20081003

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Dexxon Holdings Ltd.
		CENTRAL INDEX KEY:			0001636684
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D

	BUSINESS ADDRESS:	
		STREET 1:		1 DEXCEL STREET
		CITY:			OR AKIVA
		STATE:			L3
		ZIP:			30600000
		BUSINESS PHONE:		972-4-636404

	MAIL ADDRESS:	
		STREET 1:		1 DEXCEL STREET
		CITY:			OR AKIVA
		STATE:			L3
		ZIP:			30600000
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13D
<SEQUENCE>1
<FILENAME>v404609_sc13d.htm
<DESCRIPTION>SCHEDULE 13D
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES </B></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, DC 20549 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCHEDULE 13D </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Rule 13d-101) </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INFORMATION TO BE INCLUDED IN STATEMENTS
FILED PURSUANT </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TO &sect; 240.13d-1(a) AND AMENDMENTS
THERETO FILED </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PURSUANT TO 240.13d-2(a) </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Under the Securities Exchange Act of
1934 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Tekmira Pharmaceuticals Corporation
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Name of Issuer) </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Common Shares, no par value </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><B>(Title of Class
of Securities) </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>87911B209 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(CUSIP Number) </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Dexxon Holdings Ltd. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>1 Dexcel Street</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Or Akiva, 30600000, Israel</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>+972-4-6364040</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Name, Address and Telephone Number
of Person Authorized to Receive Notices and Communications) </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>March 4, 2015 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Date of Event Which Requires Filing
of This Statement) </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 17.25pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 17.25pt">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 17.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 17.25pt">If the filing person has previously filed
a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because
of &sect;&sect;240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. <FONT STYLE="font-family: Wingdings">&uml;</FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Note:</B> Schedules filed in paper format shall include
a signed original and five copies of the schedule, including all exhibits. See &sect;240.13d-7 for other parties to whom copies
are to be sent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 17.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 17.25pt"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 17.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 17.25pt">The information required on the remainder
of this cover page shall not be deemed to be &ldquo;filed&rdquo; for the purpose of Section 18 of the Securities Exchange Act
of 1934, as amended (the &ldquo;Act&rdquo;) or otherwise subject to the liabilities of that section of the Act but shall be subject
to all other provisions of the Act (however, see the Notes).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="vertical-align: top; width: 51%; font-size: 10pt">CUSIP No. 87911B209</td>
    <td style="vertical-align: bottom; width: 1%; font-size: 10pt">&nbsp;</td>
    <td style="vertical-align: bottom; width: 48%; font-size: 10pt; text-align: right">Page 2 of 10 Pages</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="vertical-align: top; width: 5%; border-top: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 4pt; padding-left: 8pt; font-size: 10pt">1.</td>
    <td style="vertical-align: bottom; width: 1%; border-top: black 1pt solid; border-bottom: black 1pt solid; padding-left: 0.75pt; font-size: 10pt">&nbsp;</td>
    <TD STYLE="vertical-align: top; width: 94%; border-top: black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 8pt; padding-left: 4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Name of reporting person</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0">Dexxon Holdings Ltd.</P></td></tr>
<tr>
    <td style="vertical-align: top; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 4pt; padding-left: 8pt; font-size: 10pt">2.</td>
    <td style="vertical-align: bottom; border-bottom: black 1pt solid; padding-left: 0.75pt; font-size: 10pt">&nbsp;</td>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 8pt; padding-left: 4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box if a member of a group</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(a) <FONT STYLE="font-family: Wingdings">&uml;</FONT>
        (b) <FONT STYLE="font-family: Wingdings">&uml;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P></td></tr>
<tr>
    <td style="vertical-align: top; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 4pt; padding-left: 8pt; font-size: 10pt">3.</td>
    <td style="vertical-align: bottom; border-bottom: black 1pt solid; padding-left: 0.75pt; font-size: 10pt">&nbsp;</td>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 8pt; padding-left: 4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">SEC use only</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P></td></tr>
<tr>
    <td style="vertical-align: top; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 4pt; padding-left: 8pt; font-size: 10pt">4.</td>
    <td style="vertical-align: bottom; border-bottom: black 1pt solid; padding-left: 0.75pt; font-size: 10pt">&nbsp;</td>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 8pt; padding-left: 4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Source of funds</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">OO - other</P></td></tr>
<tr>
    <td style="vertical-align: top; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 4pt; padding-left: 8pt; font-size: 10pt">5.</td>
    <td style="vertical-align: bottom; border-bottom: black 1pt solid; padding-left: 0.75pt; font-size: 10pt">&nbsp;</td>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 8pt; padding-left: 4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check box if disclosure of legal proceedings is required
        pursuant to Item 2(e) or 2(f) <FONT STYLE="font-family: Wingdings">&uml;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P></td></tr>
<tr>
    <td style="vertical-align: top; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 4pt; padding-left: 8pt; font-size: 10pt">6.</td>
    <td style="vertical-align: bottom; border-bottom: black 1pt solid; padding-left: 0.75pt; font-size: 10pt">&nbsp;</td>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 8pt; padding-left: 4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Citizenship or place of organization</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Israel</P></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td rowspan="4" style="width: 12%; border-left: black 1pt solid; padding-right: 4pt; padding-left: 8pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Number of</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">shares</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">beneficially</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">owned by</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">each</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">reporting</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">person</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">with</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P></td>
    <TD STYLE="vertical-align: bottom; width: 1%; border-bottom: black 1pt solid; border-left: Black 1pt solid; padding-left: 0.75pt">&nbsp;</td>
    <td style="vertical-align: top; width: 4%; border-bottom: black 1pt solid; padding-right: 4pt; padding-left: 4pt">7.</td>
    <td style="vertical-align: bottom; width: 1%; border-bottom: black 1pt solid; padding-left: 0.75pt">&nbsp;</td>
    <TD STYLE="vertical-align: top; width: 82%; border-bottom: black 1pt solid; border-left: Black 1pt solid; border-right: Black 1pt solid; padding-right: 8pt; padding-left: 4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-indent: -0.5pt">Sole voting power</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">0</P></td></tr>
<tr>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid; border-left: Black 1pt solid; padding-left: 0.75pt">&nbsp;</td>
    <td style="vertical-align: top; border-bottom: black 1pt solid; padding-right: 4pt; padding-left: 4pt">8.</td>
    <td style="vertical-align: bottom; border-bottom: black 1pt solid; padding-left: 0.75pt">&nbsp;</td>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: black 1pt solid; border-left: Black 1pt solid; padding-right: 8pt; padding-left: 4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Shared voting power</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">16,013,540 Shares</P></td></tr>
<tr>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid; border-left: Black 1pt solid; padding-left: 0.75pt">&nbsp;</td>
    <td style="vertical-align: top; border-bottom: black 1pt solid; padding-right: 4pt; padding-left: 4pt">9.</td>
    <td style="vertical-align: bottom; border-bottom: black 1pt solid; padding-left: 0.75pt">&nbsp;</td>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: black 1pt solid; border-left: Black 1pt solid; padding-right: 8pt; padding-left: 4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Sole dispositive power</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">0</P></td></tr>
<tr>
    <TD STYLE="vertical-align: bottom; padding-left: 0.75pt; border-left: Black 1pt solid">&nbsp;</td>
    <td style="vertical-align: top; padding-right: 4pt; padding-left: 4pt">10.</td>
    <td style="vertical-align: bottom; padding-left: 0.75pt">&nbsp;</td>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-left: Black 1pt solid; padding-right: 8pt; padding-left: 4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Shared dispositive power</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">16,013,540 Shares</P></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="vertical-align: top; width: 5%; border-top: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 4pt; padding-left: 8pt; font-size: 10pt">11.</td>
    <td style="vertical-align: bottom; width: 1%; border-top: black 1pt solid; border-bottom: black 1pt solid; padding-left: 0.75pt; font-size: 10pt">&nbsp;</td>
    <TD STYLE="vertical-align: top; width: 94%; border-top: black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 8pt; padding-left: 4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Aggregate amount beneficially owned by each reporting
        person</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">16,013,540 Shares</P></td></tr>
<tr>
    <td style="vertical-align: top; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 4pt; padding-left: 8pt; font-size: 10pt">12.</td>
    <td style="vertical-align: bottom; border-bottom: black 1pt solid; padding-left: 0.75pt; font-size: 10pt">&nbsp;</td>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 8pt; padding-left: 4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check box if the aggregate amount in Row (11) excludes
        certain shares <FONT STYLE="font-family: Wingdings">&uml;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P></td></tr>
<tr>
    <td style="vertical-align: top; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 4pt; padding-left: 8pt; font-size: 10pt">13.</td>
    <td style="vertical-align: bottom; border-bottom: black 1pt solid; padding-left: 0.75pt; font-size: 10pt">&nbsp;</td>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 8pt; padding-left: 4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Percent of class represented by amount in Row (11)</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">34.4%</P></td></tr>
<tr>
    <td style="vertical-align: top; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 4pt; padding-left: 8pt; font-size: 10pt">14.</td>
    <td style="vertical-align: bottom; border-bottom: black 1pt solid; padding-left: 0.75pt; font-size: 10pt">&nbsp;</td>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 8pt; padding-left: 4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Type of reporting person</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">CO</P></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="vertical-align: top; width: 51%">CUSIP No. 87911B209</td>
    <td style="vertical-align: bottom; width: 1%">&nbsp;</td>
    <td style="vertical-align: bottom; width: 48%; text-align: right">Page 3 of 10 Pages</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="vertical-align: top; width: 5%; border-top: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 4pt; padding-left: 8pt; font-size: 10pt">1.</td>
    <td style="vertical-align: bottom; width: 1%; border-top: black 1pt solid; border-bottom: black 1pt solid; padding-left: 0.75pt; font-size: 10pt">&nbsp;</td>
    <TD STYLE="vertical-align: top; width: 94%; border-top: black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 8pt; padding-left: 4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Name of reporting person</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dan Oren</P></td></tr>
<tr>
    <td style="vertical-align: top; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 4pt; padding-left: 8pt; font-size: 10pt">2.</td>
    <td style="vertical-align: bottom; border-bottom: black 1pt solid; padding-left: 0.75pt; font-size: 10pt">&nbsp;</td>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 8pt; padding-left: 4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box if a member of a group</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(a) <FONT STYLE="font-family: Wingdings">&uml;</FONT>
        (b) <FONT STYLE="font-family: Wingdings">&uml;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P></td></tr>
<tr>
    <td style="vertical-align: top; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 4pt; padding-left: 8pt; font-size: 10pt">3.</td>
    <td style="vertical-align: bottom; border-bottom: black 1pt solid; padding-left: 0.75pt; font-size: 10pt">&nbsp;</td>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 8pt; padding-left: 4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">SEC use only</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P></td></tr>
<tr>
    <td style="vertical-align: top; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 4pt; padding-left: 8pt; font-size: 10pt">4.</td>
    <td style="vertical-align: bottom; border-bottom: black 1pt solid; padding-left: 0.75pt; font-size: 10pt">&nbsp;</td>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 8pt; padding-left: 4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Source of funds</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">OO - other</P></td></tr>
<tr>
    <td style="vertical-align: top; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 4pt; padding-left: 8pt; font-size: 10pt">5.</td>
    <td style="vertical-align: bottom; border-bottom: black 1pt solid; padding-left: 0.75pt; font-size: 10pt">&nbsp;</td>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 8pt; padding-left: 4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check box if disclosure of legal proceedings is required
        pursuant to Item 2(e) or 2(f) <FONT STYLE="font-family: Wingdings">&uml;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P></td></tr>
<tr>
    <td style="vertical-align: top; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 4pt; padding-left: 8pt; font-size: 10pt">6.</td>
    <td style="vertical-align: bottom; border-bottom: black 1pt solid; padding-left: 0.75pt; font-size: 10pt">&nbsp;</td>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 8pt; padding-left: 4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Citizenship or place of organization</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">United States</P></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td rowspan="4" style="width: 12%; border-left: black 1pt solid; padding-right: 4pt; padding-left: 8pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Number of</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">shares</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">beneficially</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">owned by</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">each</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">reporting</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">person</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">with</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P></td>
    <TD STYLE="vertical-align: bottom; width: 1%; border-bottom: black 1pt solid; border-left: Black 1pt solid; padding-left: 0.75pt">&nbsp;</td>
    <td style="vertical-align: top; width: 4%; border-bottom: black 1pt solid; padding-right: 4pt; padding-left: 4pt">7.</td>
    <td style="vertical-align: bottom; width: 1%; border-bottom: black 1pt solid; padding-left: 0.75pt">&nbsp;</td>
    <TD STYLE="vertical-align: top; width: 82%; border-bottom: black 1pt solid; border-left: Black 1pt solid; border-right: Black 1pt solid; padding-right: 8pt; padding-left: 4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-indent: -0.5pt">Sole voting power</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">0 Shares</P></td></tr>
<tr>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid; border-left: Black 1pt solid; padding-left: 0.75pt">&nbsp;</td>
    <td style="vertical-align: top; border-bottom: black 1pt solid; padding-right: 4pt; padding-left: 4pt">8.</td>
    <td style="vertical-align: bottom; border-bottom: black 1pt solid; padding-left: 0.75pt">&nbsp;</td>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: black 1pt solid; border-left: Black 1pt solid; padding-right: 8pt; padding-left: 4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Shared voting power</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">16,013,540 Shares</P></td></tr>
<tr>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid; border-left: Black 1pt solid; padding-left: 0.75pt">&nbsp;</td>
    <td style="vertical-align: top; border-bottom: black 1pt solid; padding-right: 4pt; padding-left: 4pt">9.</td>
    <td style="vertical-align: bottom; border-bottom: black 1pt solid; padding-left: 0.75pt">&nbsp;</td>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: black 1pt solid; border-left: Black 1pt solid; padding-right: 8pt; padding-left: 4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Sole dispositive power</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">0 Shares</P></td></tr>
<tr>
    <TD STYLE="vertical-align: bottom; padding-left: 0.75pt; border-left: Black 1pt solid">&nbsp;</td>
    <td style="vertical-align: top; padding-right: 4pt; padding-left: 4pt">10.</td>
    <td style="vertical-align: bottom; padding-left: 0.75pt">&nbsp;</td>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-left: Black 1pt solid; padding-right: 8pt; padding-left: 4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Shared dispositive power</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">16,013,540 Shares</P></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="vertical-align: top; width: 5%; border-top: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 4pt; padding-left: 8pt">11.</td>
    <td style="vertical-align: bottom; width: 1%; border-top: black 1pt solid; border-bottom: black 1pt solid; padding-left: 0.75pt">&nbsp;</td>
    <TD STYLE="vertical-align: top; width: 94%; border-top: black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 8pt; padding-left: 4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Aggregate amount beneficially owned by each reporting
        person</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">16,013,540 Shares</P></td></tr>
<tr>
    <td style="vertical-align: top; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 4pt; padding-left: 8pt">12.</td>
    <td style="vertical-align: bottom; border-bottom: black 1pt solid; padding-left: 0.75pt">&nbsp;</td>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 8pt; padding-left: 4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check box if the aggregate amount in Row (11) excludes
        certain shares <FONT STYLE="font-family: Wingdings">&uml;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P></td></tr>
<tr>
    <td style="vertical-align: top; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 4pt; padding-left: 8pt">13.</td>
    <td style="vertical-align: bottom; border-bottom: black 1pt solid; padding-left: 0.75pt">&nbsp;</td>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 8pt; padding-left: 4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Percent of class represented by amount in Row (11)</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">34.4%</P></td></tr>
<tr>
    <td style="vertical-align: top; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 4pt; padding-left: 8pt">14.</td>
    <td style="vertical-align: bottom; border-bottom: black 1pt solid; padding-left: 0.75pt">&nbsp;</td>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 8pt; padding-left: 4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Type of reporting person</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">IN</P></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<tr style="vertical-align: top">
    <TD STYLE="width: 0.55in"><B>ITEM 1.</B></td>
    <TD><B>SECURITIES AND ISSUER </B></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.55in; text-indent: 0">This Schedule 13D relates to the
common shares, no par value (the &ldquo;Common Shares&rdquo;), of the Issuer. The address of the Issuer&rsquo;s principal executive
offices is at 100-8900 Glenlyon Parkway, Burnaby, British Columbia, Canada, V5J 5J8.</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<tr style="vertical-align: top">
    <TD STYLE="width: 0.55in"><B>ITEM 2.</B></td>
    <TD><B>IDENTITY AND BACKGROUND </B></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<tr style="vertical-align: top">
    <TD STYLE="width: 0.55in; font-size: 10pt">(a) &ndash; (b)</td>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to Rule 13d-1 promulgated by the SEC under
        Section 13 of the Act, this statement is being filed by:</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(i) Dexxon Holdings Ltd. (&ldquo;Dexxon&rdquo;); and</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(ii) Dan Oren.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Common Shares that may be deemed to be beneficially
        owned by each Reporting Person is set forth on Line 11 of such Reporting Person&rsquo;s cover sheet. These Common Shares
        are owned directly by Roivant Sciences Ltd. (&ldquo;Roivant&rdquo;). Dexxon may be deemed to have investment and voting
        control over the Common Shares held by Roivant by virtue of the fact that Dexxon has a representative serving as one of
        the three directors of Roivant on its behalf. Voting and dispositive decisions of Dexxon are made by its sole director,
        Dan Oren. Accordingly, Dexxon and Dan Oren may be deemed to have investment and voting control over the Common Shares
        owned by Roivant.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dexxon and Dan Oren are referred to individually as
        a &ldquo;Reporting Person&rdquo; and collectively as the &ldquo;Reporting Persons.&rdquo;</P></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.55in">The principal business address of the Reporting
Persons is 1 Dexcel Street, Or Akiva, 30600000, Israel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<tr style="vertical-align: top">
    <TD STYLE="width: 0.55in; font-size: 10pt">(c)</td>
    <TD STYLE="font-size: 10pt">Dexxon is principally engaged in the business of investing in pharmaceutical companies. Dan Oren
    is the sole director of Dexxon.</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<tr style="vertical-align: top">
    <TD STYLE="width: 0.55in">(d) &ndash; (e)</td>
    <TD>During the five years preceding the date of this filing, neither of the Reporting Persons has been (i) convicted in a
    criminal proceeding (excluding traffic violations or similar misdemeanors) or (ii) a party to a civil proceeding of a judicial
    or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree
    or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities
    laws or finding any violation with respect to such laws.</td></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</td>
    <TD>&nbsp;</td></tr>
<tr style="vertical-align: top">
    <TD>(f)</td>
    <TD>Dexxon is incorporated under the laws of Israel. Dan Oren is an Israeli citizen.</td></tr>
</table>
<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<tr style="vertical-align: top">
    <TD STYLE="width: 0.55in"><B>ITEM 3</B></td>
    <TD><B>SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION </B></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.55in">On March 4, 2015, the Issuer completed its merger
with OnCore Biopharma, Inc. (&ldquo;OnCore&rdquo;), pursuant to an Agreement and Plan of Merger, dated as of January 11, 2015
(the &ldquo;Merger Agreement&rdquo;) among the Issuer, TKM Acquisition Corporation, a wholly-owned subsidiary of the Issuer, and
OnCore. Prior to the consummation of the transactions contemplated by the Merger Agreement, Roivant owned a majority of the issued
and outstanding common stock of OnCore. Pursuant to the Merger Agreement, each share of OnCore at the effective time of the Merger
(the &ldquo;Effective Time&rdquo;) was exchanged at the exchange ratio specified in the Merger Agreement for Common Shares. Pursuant
to the Merger Agreement, Roivant exchanged its OnCore common stock for 16,013,540 Common Shares, which made Roivant beneficially
own greater than 5% of the Common Shares, and TKM Acquisition Corporation merged with and into OnCore (the &ldquo;Merger&rdquo;)
as a result of which the Issuer became the sole stockholder of the surviving entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.55in">No part of the purchase price was borrowed by any
Reporting Person for the purpose of acquiring any securities discussed in this Item 3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.25pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<tr style="vertical-align: top">
    <TD STYLE="width: 0.55in"><B>ITEM 4</B></td>
    <TD><B>PURPOSE OF TRANSACTION </B></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.55in">Roivant acquired shares of OnCore for investment
purposes and acquired its Common Shares as a result of the transactions described in Item 3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.25pt">&nbsp;</P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.25pt">The Merger Agreement, which is further described
in Item 3 above, provides that of the seven members of the Issuer&rsquo;s Board of Directors (the &ldquo;Board&rdquo;) after the
Merger, three members would be designated by OnCore (the &ldquo;OnCore Designees&rdquo;), three members would be designated by
Issuer and the designation of the seventh director would be agreed upon by the Issuer and OnCore. The three members designated
by OnCore were Vivek Ramaswamy, Keith Manchester and William Symonds (an employee of Roivant Sciences, Inc.). Mark J. Murray,
Ph.D., Richard C. Henriques, Jr., Frank Karbe and Herbert J. Conrad will be the other members of the Board after the Merger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.25pt">In accordance with the Governance Agreement (defined
below in Item 6), two of the OnCore Designees were designated by Roivant. In addition, at any future annual general or special
meeting of the Issuer&rsquo;s shareholders at which directors of the Issuer are elected, the Issuer has agreed to put forward
for nomination for election to the Board two individuals designated by Roivant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.15pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.15pt">Roivant reviews and intends to continue to review, on an ongoing and continuing basis, its investment in
the Issuer. Depending upon the factors discussed below and subject to applicable law and the agreements described in Item 6 below,
Roivant and the Reporting Persons may from time to time acquire additional securities of the Issuer or sell or otherwise dispose
of some or all of their securities of the Issuer. Any transactions that any of the Reporting Persons may pursue may be made at
any time and from time to time without prior notice and will depend upon a variety of factors, including, without limitation,
current and anticipated future trading prices of the securities of the Issuer, the financial condition, results of operations
and prospects of the Issuer, general economic, financial market and industry conditions, other investment and business opportunities
available to such Reporting Person, tax considerations and other factors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.15pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.15pt">Pursuant to the terms of the Governance Agreement,
in connection with the Merger, Tekmira will amend its articles of incorporation with the Amendment described in Item 6 below to
provide Roivant the right to designate one director to the Board for so long as Roivant has &ldquo;beneficial ownership&rdquo;
(as defined pursuant Rule 13d-3 under the Act) or exercises control or direction over not less than 10% of the outstanding Common
Shares and the right to designate up to two directors to the Board for so long as Roivant has &ldquo;beneficial ownership&rdquo;
or exercises control or direction over not less than 20% of the outstanding Common Shares, in each case subject to certain nomination
procedures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.15pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.15pt">For so long as Roivant has the right to designate
at least one director to the Board pursuant to the Amendment, the Amendment requires that the number of directors of the Board
will not exceed seven directors without the prior written consent of Roivant. Additionally, the Amendment provides that certain
actions by the Issuer will require a supermajority vote of at least 70% of the Board. The matters that require a supermajority
approval of the Board include: director nominations and appointments; equity financings over certain thresholds; significant asset
sales; mergers, reorganizations and other business combinations; the termination of certain research and development or commercialization
efforts; the incurrence of indebtedness or third party guarantees over certain thresholds; and any proposed amendments to the
Issuer&rsquo;s articles of incorporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.15pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.15pt">Additionally, the Amendment removes the right of
the chair to a second or casting vote at a meeting of the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.15pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.15pt">Other than as described above, none of the Reporting
Persons currently have plans or proposals that relate to or would result in any of the transactions involving the Issuer described
in subparagraphs (a) through (j) of Item 4 of Schedule 13D (although the Reporting Person may from time to time consider pursuing
or proposing any such transactions and, in that connection, may discuss, evaluate and/or pursue any such transactions with their
advisors, the Issuer or other persons).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<tr style="vertical-align: top">
    <TD STYLE="width: 0.53in"><B>ITEM 5</B></td>
    <TD><B>INTEREST IN SECURITIES OF THE ISSUER </B></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.25pt">The information contained on each of the cover
pages of this Schedule 13D and the information set forth or incorporated in Items 2, 3, 4, and 6 are hereby incorporated herein
by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<tr style="vertical-align: top">
    <TD STYLE="width: 0.53in; font-size: 10pt">(a) &ndash; (b)</td>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Aggregate number and percentage of Common Shares beneficially
        owned by each Reporting Person as of the date hereof: 16,013,540 Common Shares. These Common Shares are owned directly
        by Roivant. Dexxon may be deemed to have investment and voting control over the Common Shares held by Roivant by virtue
        of the fact that Dexxon has a representative serving as one of the three directors of Roivant on its behalf. Voting and
        dispositive decisions of Roivant require unanimous approval by the three directors of Roivant. Voting and
        dispositive decisions of Dexxon are made by its sole director, Dan Oren. Accordingly, Dexxon and Dan Oren may be deemed
        to have investment and voting control over the Common Shares owned by Roivant.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The percentage of outstanding Common Shares of the
        Issuer that may be deemed to be beneficially owned by each Reporting Person is set forth on Line 13 of such Reporting
        Person&rsquo;s cover sheet.&nbsp;&nbsp;Such percentage was calculated for each Reporting Person based on an aggregate
        of 46,567,496 Common Shares issued and outstanding as of March 9, 2015 reported on the Issuer&rsquo;s annual report on
        Form 10-K, filed with the SEC on March 13, 2015, which includes the 23,973,315 Common Shares (the &ldquo;Merger Shares&rdquo;)
        reported to be issued in connection with the Merger and outstanding immediately after the Effective Time.&nbsp;&nbsp;&nbsp;&nbsp;</P></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <TD STYLE="width: 8%; font-size: 10pt">&nbsp;</td>
    <TD STYLE="width: 92%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Except as disclosed in this Schedule 13D, none of the
        Reporting Persons beneficially owns any Common Shares or has the right to acquire any Common Shares.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Except as disclosed in this Schedule 13D, none of the
        Reporting Persons presently has the power to vote or to direct the vote or to dispose or direct the disposition of any
        of the Shares that they may be deemed to beneficially own.</P></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 8%; font-size: 10pt">(c)</td>
    <td style="width: 92%; font-size: 10pt">Except as described in this Schedule 13D, none of the Reporting Persons has effected
    any transactions in shares of the Common Shares during the last 60 days.</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <TD STYLE="width: 0.55in; font-size: 10pt">(d)</td>
    <TD STYLE="font-size: 10pt">To the best knowledge of the Reporting Persons, no other person has the right to receive or the
    power to direct the receipt of dividends from, or the proceeds from the sale of, the Common Shares beneficially owned by the
    Reporting Persons.</td></tr>
<tr style="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</td>
    <TD STYLE="font-size: 10pt">&nbsp;</td></tr>
<tr style="vertical-align: top">
    <TD STYLE="font-size: 10pt">(e)</td>
    <TD STYLE="font-size: 10pt">Not applicable.</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <TD STYLE="width: 0.55in; font-size: 10pt"><B>ITEM 6.</B></td>
    <TD STYLE="font-size: 10pt"><B>CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO SECURITIES OF THE
    ISSUER. </B></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.25pt"><U>Registration Rights Agreement</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.25pt">The Common Shares issuable in the Merger have not
been, and as of the Effective Time, were not registered under the Securities Act of 1933 and may not be offered or sold in the
United States absent registration or an applicable exemption from registration requirements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.25pt">Pursuant to the Merger Agreement, the Issuer has
entered into a Registration Rights Agreement (the &ldquo;Registration Rights Agreement&rdquo;) with certain of the stockholders
of OnCore (the &ldquo;OnCore Holders&rdquo;), including Roivant. The Registration Rights Agreement requires the Issuer, after
the Effective Time, to file a resale registration statement with the SEC registering for resale (i) the Merger Shares issuable
to such OnCore Holders, including Roivant, and (ii) any additional Common Shares issued as a dividend or other distribution with
respect to, or in exchange for, or in replacement of, any Merger Shares. The Issuer has agreed to cause the registration statement
to be declared effective on or prior to the date that any OnCore Holders may sell or dispose of its Merger Shares under the terms
of the OnCore Holders&rsquo; respective Lock-Up Agreements (as discussed below). Additionally, the OnCore Holders will have certain
customary demand and piggy-back registration rights, subject to certain underwriter cutbacks. Under the Registration Rights Agreement,
the Issuer will generally pay for the registration expenses (excluding underwriting discounts and commissions), and each party
will have customary indemnification obligations to the other parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.25pt"><U>Lock-Up Agreement</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.25pt">Concurrently with the execution of the Merger Agreement,
Roivant and certain other OnCore Holders and certain directors, officers and shareholders of the Issuer have entered into lock-up
agreements with the Issuer (collectively, the &ldquo;Lock-Up Agreements&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.25pt">Pursuant to the terms of the Lock-Up Agreements,
Roivant and the other OnCore Holders have agreed, subject to certain exceptions, not to sell or otherwise dispose of any of their
respective Common Shares (including any Merger Shares received by them) for a period of 27 months following the Effective Time;
provided that (i) an aggregate of 25% of their respective shares will be released after 9 months following the Effective Time,
(ii) an additional aggregate of 10% of their respective shares will be released in each of the subsequent five quarters thereafter
and (iii) the remaining aggregate of 25% of their respective shares will be released after 27 months from the Effective Time.
Additionally, the Lock-Up Agreement between Roivant and the Issuer (the &ldquo;Roivant Lock-Up&rdquo;) provides that upon certain
material breaches of the Governance Agreement (as discussed below) by the Issuer that remain uncured after thirty (30) days, all
shares subject to the Roivant Lock-Up will be released from the provisions of the Roivant Lock-Up.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.25pt"><U>Governance Agreement</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.25pt">Pursuant to the Merger Agreement, the Issuer and
Roivant entered into a Governance Agreement (the &ldquo;Governance Agreement&rdquo;) relating to the composition of the Board
and certain other corporate governance matters. In connection with the Governance Agreement, the Issuer shall amend its articles
of incorporation (the &ldquo;Amendment&rdquo;), to be effective as of the Effective Time to provide Roivant the right to designate
one (1) director to the Board for so long as Roivant has &ldquo;beneficial ownership&rdquo; (as defined pursuant Rule 13d-3 under
the Act) or exercises control or direction over not less than 10% of the outstanding Common Shares and the right to designate
up to two (2) directors to the Board for so long as Roivant has &ldquo;beneficial ownership&rdquo; or exercises control or direction
over not less than 20% of the outstanding Common Shares, in each case subject to certain nomination procedures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.25pt">&nbsp;</P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.25pt">For so long as Roivant has the right to designate
at least one (1) director to the Board pursuant to the Amendment, the Amendment will require that the number of directors on the
Board will not exceed seven (7) directors without the prior written consent of Roivant. Additionally, the Amendment will provide
that certain actions by the Issuer will require a supermajority vote of at least 70% of the Board. The matters that require a
supermajority approval of the Board include: director nominations and appointments; equity financings over certain thresholds;
significant asset sales; mergers, reorganizations and other business combinations; the termination of certain R&amp;D or commercialization
efforts; the incurrence of indebtedness of third party guarantees over certain thresholds; and any proposed amendments to the
Issuer&rsquo;s articles.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.25pt">Roivant&rsquo;s director designation rights and
the supermajority board voting requirements will be effective upon the Effective Time and will expire upon the earlier of (i)
36 months from the Effective Time and (ii) when Roivant has &ldquo;beneficial ownership&rdquo; or exercises control or direction
over less than 10% of the outstanding Common Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.25pt">The Governance Agreement also provides that from
and after the Effective Time and until the earlier of (i) 36 months from the Effective Time and (ii) when Roivant no longer has
the right to designate one or more directors to the Board pursuant to the terms of the Amendment (the &ldquo;Governance Period&rdquo;),
the Issuer will put forward for nomination and election at each meeting of the Issuer&rsquo;s shareholders for the election of
directors Roivant&rsquo;s director designees and Roivant shall vote in favor of all such director nominees put forward by the
Issuer for election to the Board and shall vote against the election of any person nominated by anyone other than the Board. The
Governance Agreement also subjects Roivant to certain obligations of confidentiality during the Governance Period with respect
to the Issuer&rsquo;s confidential information. Additionally, the Governance Agreement requires that throughout the Governance
Period, the Issuer shall use its reasonable efforts to avoid, in respect of any taxable year, being treated as a passive foreign
investment company within the meaning of Section 1297 of the Internal Revenue Code of 1986, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.25pt"><U>Standstill Agreement</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.25pt">Pursuant to the Merger Agreement, the Issuer and
Roivant entered into a standstill agreement (the &ldquo;Standstill Agreement&rdquo;). Under the terms of the Standstill Agreement,
Roivant has agreed that, until the earlier of (i) three years after the Effective Date of the Merger and (ii) such time as Roivant
no longer has the right to nominate at least one director to the Board pursuant to the terms of the Governance Agreement, Roivant
shall not acquire, offer to acquire, or agree to acquire ownership of any additional Common Shares of the Issuer, or take certain
other actions related to the calling of meetings, proxies, proposals and other actions of the shareholders of the Issuer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.25pt">The summaries of the Merger Agreement, the Registration
Rights Agreement, the Roivant Lock-Up Agreement, the Governance Agreement, the Amendment and the Standstill Agreement contained
in Item 3, Item 4 and Item 6 are qualified in their entirety by reference to the Merger Agreement, the Registration Rights Agreement,
the Roivant Lock-Up Agreement, the Governance Agreement, the Amendment and the Standstill Agreement, each of which is filed as
exhibit hereto and incorporated by reference herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.25pt">&nbsp;</P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <TD STYLE="width: 0.55in; font-size: 10pt"><B>ITEM 7.</B></td>
    <TD STYLE="font-size: 10pt"><B>MATERIAL TO BE FILED AS EXHIBITS. </B></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <TD STYLE="vertical-align: top; width: 12%">Exhibit 7.01</td>
    <TD STYLE="vertical-align: bottom; width: 1%">&nbsp;</td>
    <TD STYLE="vertical-align: top; width: 87%">Agreement and Plan of Merger and Reorganization, dated January 11, 2015, by and
    among Tekmira Pharmaceuticals Corporation, TKM Acquisition Corporation and OnCore Biopharma, Inc. (incorporated by reference
    to Annex A to the Issuer&rsquo;s proxy statement/circular filed on Schedule 14A with the Securities and Exchange Commission
    on February 4, 2015)</td></tr>
<tr>
    <TD STYLE="vertical-align: top">&nbsp;</td>
    <TD STYLE="vertical-align: bottom">&nbsp;</td>
    <TD STYLE="vertical-align: top">&nbsp;</td></tr>
<tr>
    <TD STYLE="vertical-align: top">Exhibit 7.02</td>
    <TD STYLE="vertical-align: bottom">&nbsp;</td>
    <TD STYLE="vertical-align: top">Registration Rights Agreement, dated as of January 11, 2015, by and among the Issuer and the
    OnCore Holders (incorporated by reference to Annex E to the Issuer&rsquo;s proxy statement/circular filed on Schedule 14A
    with the Securities and Exchange Commission on February 4, 2015).</td></tr>
<tr>
    <TD>&nbsp;</td>
    <td colspan="2">&nbsp;</td></tr>
<tr>
    <TD STYLE="vertical-align: top">Exhibit 7.03</td>
    <TD STYLE="vertical-align: bottom">&nbsp;</td>
    <TD STYLE="vertical-align: top">Roivant Lock-Up Agreement, dated as of January 11, 2015, by Roivant (incorporated by reference
    to Annex F to the Issuer&rsquo;s proxy statement/circular filed on Schedule 14A with the Securities and Exchange Commission
    on February 4, 2015).</td></tr>
<tr>
    <TD STYLE="vertical-align: top">&nbsp;</td>
    <TD STYLE="vertical-align: bottom">&nbsp;</td>
    <TD STYLE="vertical-align: top">&nbsp;</td></tr>
<tr>
    <TD STYLE="vertical-align: top">Exhibit 7.04</td>
    <TD STYLE="vertical-align: bottom">&nbsp;</td>
    <TD STYLE="vertical-align: top">Form of Lock-Up Agreement, dated as of January 11, 2015, entered into by certain stockholders
    of OnCore (incorporated by reference to Annex F to the Issuer&rsquo;s proxy statement/circular filed on Schedule 14A with
    the Securities and Exchange Commission on February 4, 2015).</td></tr>
<tr>
    <TD>&nbsp;</td>
    <td colspan="2">&nbsp;</td></tr>
<tr>
    <TD STYLE="vertical-align: top">Exhibit 7.05</td>
    <TD STYLE="vertical-align: bottom">&nbsp;</td>
    <TD STYLE="vertical-align: top">Governance Agreement, dated as of January 11, 2015, by and between the Issuer and Roivant
    (incorporated by reference to Annex G to the Issuer&rsquo;s proxy statement/circular filed on Schedule 14A with the Securities
    and Exchange Commission on February 4, 2015).</td></tr>
<tr>
    <TD>&nbsp;</td>
    <td colspan="2">&nbsp;</td></tr>
<tr>
    <TD STYLE="vertical-align: top">Exhibit 7.06</td>
    <TD STYLE="vertical-align: bottom">&nbsp;</td>
    <TD STYLE="vertical-align: top"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Amendment to the Issuer&rsquo;s Articles of Incorporation
        (incorporated by reference to Annex C to the Issuer&rsquo;s proxy statement/circular filed on Schedule 14A with the Securities
        and Exchange Commission on February 4, 2015).</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></td></tr>
<tr>
    <TD STYLE="vertical-align: top">Exhibit 7.07</td>
    <TD STYLE="vertical-align: bottom">&nbsp;</td>
    <TD STYLE="vertical-align: top"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Standstill Agreement, dated as of January 11, 2015,
        by and among the Issuer and Roivant (incorporated by reference to Annex H to the Issuer&rsquo;s proxy statement/circular
        filed on Schedule 14A with the Securities and Exchange Commission on February 4, 2015).&nbsp;</P></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SIGNATURE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 17.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 17.25pt">After reasonable inquiry and to the best
of my knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 17.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dated: March 16, 2015</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Dexxon Holdings Ltd.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: center; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: center; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <TD STYLE="width: 4%">By:</td>
    <TD STYLE="width: 36%; border-bottom: Black 1pt solid">/s/ Dan Oren</td>
    <TD STYLE="width: 60%">&nbsp;</td></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</td>
    <TD>Name: Dan Oren</td>
    <TD>&nbsp;</td></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</td>
    <TD>Title: Director</td>
    <TD>&nbsp;</td></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td></tr>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><B>Dan Oren</B></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<tr style="vertical-align: top">
    <td colspan="2" style="border-bottom: Black 1pt solid">/s/ Dan Oren</td>
    <TD>&nbsp;</td></tr>
<tr style="vertical-align: top">
    <td colspan="2">Dan Oren</td>
    <TD>&nbsp;</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Exhibit Index</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <TD STYLE="vertical-align: top; width: 12%">Exhibit 7.01</td>
    <TD STYLE="vertical-align: bottom; width: 1%">&nbsp;</td>
    <TD STYLE="vertical-align: top; width: 87%">Agreement and Plan of Merger and Reorganization, dated January 11, 2015, by and
    among Tekmira Pharmaceuticals Corporation, TKM Acquisition Corporation and OnCore Biopharma, Inc. (incorporated by reference
    to Annex A to the Issuer&rsquo;s proxy statement/circular filed on Schedule 14A with the Securities and Exchange Commission
    on February 4, 2015)</td></tr>
<tr>
    <TD STYLE="vertical-align: top">&nbsp;</td>
    <TD STYLE="vertical-align: bottom">&nbsp;</td>
    <TD STYLE="vertical-align: top">&nbsp;</td></tr>
<tr>
    <TD STYLE="vertical-align: top">Exhibit 7.02</td>
    <TD STYLE="vertical-align: bottom">&nbsp;</td>
    <TD STYLE="vertical-align: top">Registration Rights Agreement, dated as of January 11, 2015, by and among the Issuer and the
    OnCore Holders (incorporated by reference to Annex E to the Issuer&rsquo;s proxy statement/circular filed on Schedule 14A
    with the Securities and Exchange Commission on February 4, 2015).</td></tr>
<tr>
    <TD>&nbsp;</td>
    <td colspan="2">&nbsp;</td></tr>
<tr>
    <TD STYLE="vertical-align: top">Exhibit 7.03</td>
    <TD STYLE="vertical-align: bottom">&nbsp;</td>
    <TD STYLE="vertical-align: top">Roivant Lock-Up Agreement, dated as of January 11, 2015, by Roivant (incorporated by reference
    to Annex F to the Issuer&rsquo;s proxy statement/circular filed on Schedule 14A with the Securities and Exchange Commission
    on February 4, 2015).</td></tr>
<tr>
    <TD STYLE="vertical-align: top">&nbsp;</td>
    <TD STYLE="vertical-align: bottom">&nbsp;</td>
    <TD STYLE="vertical-align: top">&nbsp;</td></tr>
<tr>
    <TD STYLE="vertical-align: top">Exhibit 7.04</td>
    <TD STYLE="vertical-align: bottom">&nbsp;</td>
    <TD STYLE="vertical-align: top">Form of Lock-Up Agreement, dated as of January 11, 2015, entered into by certain stockholders
    of OnCore (incorporated by reference to Annex F to the Issuer&rsquo;s proxy statement/circular filed on Schedule 14A with
    the Securities and Exchange Commission on February 4, 2015).</td></tr>
<tr>
    <TD>&nbsp;</td>
    <td colspan="2">&nbsp;</td></tr>
<tr>
    <TD STYLE="vertical-align: top">Exhibit 7.05</td>
    <TD STYLE="vertical-align: bottom">&nbsp;</td>
    <TD STYLE="vertical-align: top">Governance Agreement, dated as of January 11, 2015, by and between the Issuer and Roivant
    (incorporated by reference to Annex G to the Issuer&rsquo;s proxy statement/circular filed on Schedule 14A with the Securities
    and Exchange Commission on February 4, 2015).</td></tr>
<tr>
    <TD>&nbsp;</td>
    <td colspan="2">&nbsp;</td></tr>
<tr>
    <TD STYLE="vertical-align: top">Exhibit 7.06</td>
    <TD STYLE="vertical-align: bottom">&nbsp;</td>
    <TD STYLE="vertical-align: top"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Amendment to the Issuer&rsquo;s Articles of Incorporation
        (incorporated by reference to Annex C to the Issuer&rsquo;s proxy statement/circular filed on Schedule 14A with the Securities
        and Exchange Commission on February 4, 2015).</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></td></tr>
<tr>
    <TD STYLE="vertical-align: top">Exhibit 7.07</td>
    <TD STYLE="vertical-align: bottom">&nbsp;</td>
    <TD STYLE="vertical-align: top">Standstill Agreement, dated as of January 11, 2015, by and among the Issuer and Roivant (incorporated
    by reference to Annex H to the Issuer&rsquo;s proxy statement/circular filed on Schedule 14A with the Securities and Exchange
    Commission on February 4, 2015).</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 10; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
